Trial Activity Snapshot: Did Australia’s “zero-Covid” plan protect clinical trial activity?
In an exclusive, Clinical Trials Arena dives into Australia’s trial activity data to find out how the pandemic impacted the…
By
Homepage
Latest in
Homepage
Biosimilars: top 10 pharma companies leading the way
The analysis is influenced by new biosimilars jobs, deals, patents, and mentions in company reports since January 2021.
By
Pipeline Moves: J&J ends ulcerative colitis trial, further study chances drop
Clinical Trials Arena reviews a total of six trials, including ones in gram-negative bacterial infections, hepatitis B, and obesity.
By
Moderna eyes combined Covid-19, flu booster by 2023
Moderna CEO Stéphane Bancel also said an Omicron-specific Covid-19 vaccine will enter clinical development in a matter of weeks.
By
Mapping Endpoints: How to build an ALS clinical trial
Differing endpoint and efficacy expectations can make designing an ALS clinical trial challenging. Clinical Trials Arena looks at ways to…
By
Pipeline Moves: GSK’s likelihood of further study in tuberculosis rises
Stuart Therapeutics in dry eye disease and Vifor Pharma in beta thalassemia are also reviewed by Clinical Trials Arena.
By
ALS: drug trial results to watch in 2022
Pharma companies are pouring more efforts into ALS studies, setting the stage for several major drug trial readouts this year.
By